The University of Texas M.D. Anderson Cancer Center is one of the original 3 cancer treatment centers established after the 1971 National Cancer Act. It is a degree awarding institution and is connected to the University of Texas Medical Centers in Houston. Today the M.D. Anderson Cancer Center is one of the finest cancer treatment and research hospitals rivaled only by the Sloan-Kettering Cancer Center in New York. There are approximately 36 other cancer treatment centers designated by the National Cancer Institute as cancer centers. It is a 512 bed hospital with a Level 1 Trauma Center that employs over 17,000 professionals and support staff. The M.D. Anderson Cancer Center offers fellowships, internships and residency opportunities. The Center can trace its inception to 1941 by virtue of an act of the Texas Legislature.
Same protein that fires up cancer-promoting Erk also blocks its activation
A protein which is intimately involved in cancer-promoting cell signaling also keeps a key component of the signaling pathway tied down and inactive, a team led by scientists from The University of Texas MD Anderson Cancer ...
Apr 19, 2013
5 / 5 (1)
0
| 
Scientists uncover the nuclear life of actin
A key building block of life, actin is one of the most abundant and highly conserved proteins in eukaryotic cells.
Mar 24, 2013
4.9 / 5 (9)
0
|
Scientists discover secret life of chromatin
Chromatin - the intertwined histone proteins and DNA that make up chromosomes – constantly receives messages that pour in from a cell’s intricate signaling networks: Turn that gene on. Stifle that one.
Sep 01, 2011
4 / 5 (2)
0
|
Protein identified as enemy of vital tumor suppressor PTEN
A protein known as WWP2 appears to play a key role in tumor survival, a research team headed by a scientist at The University of Texas MD Anderson Cancer Center reports in an advance online publication of Nature Cell Biology.
May 03, 2011
5 / 5 (1)
0
|
Genetic variation cuts bladder cancer risk, protects chromosome tips
A common genetic variation links to both bladder cancer risk and to the length of protective caps found on the ends of chromosomes, scientists at The University of Texas MD Anderson Cancer Center reported today at the AACR ...
Apr 02, 2011
not rated yet
0
'Good cholesterol' nanoparticles seek and destroy cancer cells
High-density lipoprotein's hauls excess cholesterol to the liver for disposal, but new research suggests "good cholesterol" can also act as a special delivery vehicle of destruction for cancer.
Apr 01, 2011
5 / 5 (8)
2
|
UT MD Anderson receives grant for study of acupuncture in cancer
The University of Texas MD Anderson Cancer Center has been awarded a grant to study whether xerostomia, a debilitating side effect caused by head and neck cancer radiation treatment, can be prevented when acupuncture is part ...
Mar 22, 2011
5 / 5 (1)
0
Study puts notch on the jagged edge of lung cancer metastasis
Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial. The study was published today (Monday, March 14) in the Journal of Clinical In ...
Mar 14, 2011
5 / 5 (1)
0
Combination overcomes breast cancer resistance to herceptin
Breast cancer tumors take numerous paths to resist the targeted drug Herceptin, but a single roadblock at a crucial crossroads may restore a tumor's vulnerability to treatment, scientists at The University of Texas MD Anderson ...
Mar 13, 2011
4 / 5 (2)
0
|
Protein and microRNA block cellular transition vital to metastasis
Like a bounty hunter returning escapees to custody, a cancer-fighting gene converts organ cells that change into highly mobile stem cells back to their original, stationary state, researchers report online at Nature Cell Bi ...
Feb 25, 2011
4.8 / 5 (4)
0
|
Overabundance of protein expands breast cancer stem cells
An essential protein for normal stem cell renewal also promotes the growth of breast cancer stem cells when it's overproduced in those cells, researchers at The University of Texas MD Anderson Cancer Center report in the ...
Feb 15, 2011
not rated yet
0
|
Everolimus improves progression-free survival for patients with rare pancreatic cancer
In an international Phase III randomized study, everolimus, an inhibitor of the mammalian target of rapamycin (mTOR), has shown to dramatically improve progression-free survival for patients with advanced pancreatic neuroendocrine ...
Feb 09, 2011
5 / 5 (1)
0
Project connects researchers, Latino communities to prevent cancer
A $4 million, five-year grant from the National Cancer Institute will create a Texas regional Community Networks Program Center (CNPC), called Latinos Contra El Cancer, to reduce cancer-related health disparities among Texas ...
Feb 07, 2011
not rated yet
0
Targeted particle fools brain's guardian to reach tumors
A targeted delivery combination selectively crosses the tight barrier that protects the brain from the bloodstream to home in on and bind to brain tumors, a research team led by scientists from The University of Texas MD ...
Feb 01, 2011
5 / 5 (5)
0
|
Pre-surgical stress management boosts immune function, lowers mood disturbance in prostate cancer patients
Practicing stress management techniques before prostate cancer surgery may help activate the body's immune response leading to quicker recovery, as well as aid in lowering mood disturbance, according to a new study by researchers ...
Jan 28, 2011
not rated yet
0
